Edition:
India

People: Alder Biopharmaceuticals Inc (ALDR.OQ)

ALDR.OQ on NASDAQ Stock Exchange Global Market

18.50USD
16 Sep 2019
Change (% chg)

$8.44 (+83.90%)
Prev Close
$10.06
Open
$18.48
Day's High
$18.87
Day's Low
$18.34
Volume
6,860,609
Avg. Vol
336,924
52-wk High
$18.87
52-wk Low
$8.39

Bucher, James 

Mr. James B. Bucher, J.D., is Executive Vice President, General Counsel of the Company. Mr. Bucher has served as our Executive Vice President and General Counsel since February 2019 and served as our Senior Vice President and General Counsel from January 2016 to February 2019. During 2015, Mr. Bucher served as a consultant providing legal services to several life sciences companies. From 2007 to 2014, Mr. Bucher served as Vice President, Corporate Legal Affairs and Secretary, and as the Corporate Compliance Officer, of Exelixis, Inc., a biopharmaceutical company. From 1991 to 2007, Mr. Bucher practiced as a corporate attorney at the international law firm Shearman & Sterling LLP, becoming a partner in 2001. Mr. Bucher holds a J.D. with distinction from Emory University School of Law and a B.A. in Biology from Colgate University.

Basic Compensation

Total Annual Compensation, USD 397,708
Restricted Stock Award, USD 232,413
Long-Term Incentive Plans, USD 182,946
All Other, USD 1,148,470
Fiscal Year Total, USD 1,961,540

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Azelby

10,130,800

Carlos Campoy

1,844,370

Erin Lavelle

3,680,390

James Bucher

1,961,540

Randal Hassler

4,217,190

Nadia Dac

--
As Of  31 Dec 2018